Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance
- PMID: 23548968
- DOI: 10.1159/000349956
Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance
Abstract
Background: MicroRNAs have been reported to play roles as oncogenes or tumor suppressor genes in human cancers. However, the expression levels of miR-145 in oral squamous cell carcinoma (OSCC) are unclear. The purpose of this study was to investigate the status of miR-145 expression in OSCC and determine its clinical significance.
Patients and methods: We examined miR-145 levels in 62 OSCC tissue samples and cell lines by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). The relationship between miR-145 expression and clinicopathologic factors of OSCC patients was analyzed.
Results: The proportion of miR-145 low expression was 82.26% (51/62) among the 62 OSCC patients, and expression levels of miR-145 in OSCC tissue samples and cell lines were significantly lower than in non-tumor controls. miR-145 expression levels were not significantly associated with age (p = 0.607), sex (p = 0.213), location (p = 0.952), histology (p = 0.603), pT stage (p = 0.305), pTNM stage (p = 0.471), and lymphatic metastasis (p = 1.000).
Conclusion: miR-145 may be involved in the early tumorigenesis of oral squamous cells, and might be a potential biomarker in the early diagnosis of OSCC.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
-
Amplification and up-regulation of microRNA-30b in oral squamous cell cancers.Arch Oral Biol. 2012 Aug;57(8):1012-7. doi: 10.1016/j.archoralbio.2012.04.002. Epub 2012 Apr 26. Arch Oral Biol. 2012. PMID: 22542163
-
Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20868995
-
Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.Oncogene. 2012 May 10;31(19):2401-11. doi: 10.1038/onc.2011.423. Epub 2011 Sep 19. Oncogene. 2012. PMID: 21927029
-
MicroRNAs: new actors in the oral cancer scene.Oral Oncol. 2011 May;47(5):314-9. doi: 10.1016/j.oraloncology.2011.03.019. Epub 2011 Apr 6. Oral Oncol. 2011. PMID: 21474366 Review.
-
MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer.J Cell Physiol. 2016 Jul;231(7):1424-31. doi: 10.1002/jcp.25269. Epub 2015 Dec 28. J Cell Physiol. 2016. PMID: 26620726 Review.
Cited by
-
MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.Biomed Res Int. 2015;2015:186904. doi: 10.1155/2015/186904. Epub 2015 Oct 4. Biomed Res Int. 2015. PMID: 26504785 Free PMC article. Review.
-
miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10.Mol Med Rep. 2020 Feb;21(2):705-719. doi: 10.3892/mmr.2019.10856. Epub 2019 Nov 29. Mol Med Rep. 2020. PMID: 31789419 Free PMC article.
-
A Looking-Glass of Non-coding RNAs in oral cancer.Int J Mol Sci. 2017 Dec 5;18(12):2620. doi: 10.3390/ijms18122620. Int J Mol Sci. 2017. PMID: 29206174 Free PMC article. Review.
-
Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line.Tumour Biol. 2014 Apr;35(4):2983-8. doi: 10.1007/s13277-013-1383-x. Epub 2013 Nov 19. Tumour Biol. 2014. PMID: 24248543
-
Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.Oncol Rep. 2021 Mar;45(3):1094-1104. doi: 10.3892/or.2020.7908. Epub 2020 Dec 24. Oncol Rep. 2021. Retraction in: Oncol Rep. 2022 May;47(5):95. doi: 10.3892/or.2022.8306 PMID: 33650645 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
